This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Convatec, Lilly Foundation Fund...
Business charitable donation

Convatec, Lilly Foundation Fund Partners_In_Health

Analysis based on 6 articles · First reported Jun 09, 2026 · Last updated Jun 09, 2026

Sentiment
50
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The commitment of approximately $5 million by Convatec and the Eli Lilly and Company to Partners In Health is a positive development for the healthcare sector, particularly in global health initiatives. While not directly impacting stock prices significantly, it enhances the corporate social responsibility and public image of Convatec and Eli Lilly and Company, potentially attracting socially conscious investors.

Healthcare Pharmaceuticals
Event Summary

Convatec and the Eli Lilly and Company have jointly committed approximately $5 million to Partners In Health, an international nonprofit global health organization. This funding aims to accelerate the integration of non-communicable disease (NCD) and chronic care, including cardiometabolic and mental health, into primary and community health systems in resource-limited settings. The initiative builds on Convatec's existing collaboration with Partners In Health since 2023, which has already reached over 300,000 people. The new phase of collaboration will focus on scaling innovative approaches to training Community Health Workers, supporting locally delivered care, and strengthening referral pathways in countries like Peru, Rwanda, Malawi, and Sierra Leone. It also includes a new partnership with the University of Global Health Equity in Rwanda to prepare future healthcare leaders. This commitment honors the legacy of Karim Bitar, Convatec's former CEO, who passed away in October 2025.

Entities Involved
ngo
Partners In Health
Partners In Health received approximately $5 million from Convatec and the Eli Lilly and Company to scale its integrated models of care for non-communicable diseases and chronic conditions in resource-limited settings. This funding will significantly expand its programs.
Importance 100.0 Sentiment 60.0
stock
Convatec
Convatec committed approximately $5 million to Partners In Health, continuing its collaboration to improve chronic care in resource-limited settings. This initiative honors the legacy of its former CEO, Karim Bitar, and enhances Convatec's corporate social responsibility profile.
Importance 90.0 Sentiment 20.0
stock
Eli Lilly and Company
Eli Lilly and Company supports the Eli Lilly and Company, which committed approximately $5 million to Partners In Health. This contributes to its philanthropic efforts in global health.
Importance 70.0 Sentiment 10.0
per
Karim Bitar
Karim Bitar, the former CEO of Convatec, is honored through this new collaboration between Convatec and Partners In Health, which builds on his belief in collective action and long-term healthcare partnerships.
Importance 50.0 Sentiment 0.0
oth
University of Global Health Equity
The University of Global Health Equity in Rwanda will engage in a new collaboration with Partners In Health, supported by the funding, to prepare future healthcare changemakers.
Importance 20.0 Sentiment 0.0
cnt
Rwanda
Rwanda is a key geography for Partners In Health programs, including a new collaboration with the University of Global Health Equity, benefiting from the committed funds to improve NCD and chronic care.
Importance 20.0 Sentiment 0.0
per
Jonny Mason
Jonny Mason, CEO of Convatec, expressed pride in the collaboration with Partners In Health and its expansion in memory of Karim Bitar.
Importance 10.0 Sentiment 0.0
per
David A. Ricks
David A. Ricks, Chair and CEO of Eli Lilly and Company and Chair of the Eli Lilly and Company, highlighted the importance of strengthening local health systems through the grant to Partners In Health.
Importance 10.0 Sentiment 0.0
per
Sheila Davis
Sheila Davis, CEO of Partners In Health, expressed honor in working with Convatec and receiving support from the Eli Lilly and Company to expand access to quality care for chronic conditions.
Importance 10.0 Sentiment 0.0
cnt
Sierra Leone
Sierra Leone is one of the resource-limited settings where Partners In Health's charitable work, supported by the Eli Lilly and Company grant, will integrate cardiometabolic and NCD care into primary care systems.
Importance 10.0 Sentiment 0.0
cnt
Peru
Peru is one of the geographies where Partners In Health programs, supported by the new funding, will be implemented to strengthen health systems.
Importance 10.0 Sentiment 0.0
cnt
Malawi
Malawi is one of the resource-limited settings where Partners In Health's charitable work, supported by the Eli Lilly and Company grant, will integrate cardiometabolic and NCD care into primary care systems.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.